Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands

被引:9
|
作者
Paskins, Z
Potter, T
Erb, N
Obrenovic, K
Rowe, IF
机构
[1] Univ Hosp Coventry, Dept Rheumatol, Coventry, W Midlands, England
[2] Warwickshire NHS Trust, Coventry, W Midlands, England
[3] Dudley Grp Hosp NHS Trust, Dudley, England
关键词
corticosteroid-induced osteoporosis; guidelines; regional audit;
D O I
10.7861/clinmedicine.6-2-183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The management of corticosteroid-induced osteoporosis in rheumatology outpatients in the West Midlands was audited in relation to the 2002 Royal College of Physicians (RCP) Guidelines and re-audited in relation to the 1998 National Osteoporosis Society (NOS) Guidance. Practice was assessed from prospective data on all follow-up patients over a 2-week period in 13 rheumatology units. Data were analysed on 2,609 patients. Of the 626 patients fulfilling criteria for assessment against the RCP Guidelines, 351 (56.1%) were treated appropriately. The results do not allow for availability of, or wait for, DEXA scanning. Of 197 patients fulfilling the criteria for assessment against the NOS Guidance, 137 (69.5%) were treated appropriately, compared to 63% in a similar audit undertaken in 2000. Regional audit may facilitate clinical governance. These audits will inform discussion on both improving local practice and strengthening cases for improved osteoporosis services.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 50 条
  • [41] Bisphosphonates - Role in treatment of corticosteroid-induced osteoporosis
    Gallacher, SJ
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 6 (02): : 154 - 162
  • [42] Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis
    W. F. Lems
    W. G. Jacobs
    J. W. J. Bijlsma
    A. Croone
    H. C. M. Haanen
    H. H. M. L. Houben
    M. I. Gerrits
    H. J. M. van Rijn
    Osteoporosis International, 1997, 7 : 575 - 582
  • [43] Prevention of corticosteroid-induced osteoporosis - Results of a patient survey
    Buckley, LM
    Marquez, M
    Feezor, R
    Ruffin, DM
    Benson, LL
    ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1736 - 1739
  • [44] Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacaleidol
    Dequeker, J
    Borghs, H
    Van Cleemput, J
    Nevens, F
    Verleden, G
    Nijs, J
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2000, 59 : 53 - 57
  • [45] CORTICOSTEROID-INDUCED OSTEOPOROSIS - FROM PATHOGENESIS TO TREATMENT
    AUDRAN, M
    BASLE, MF
    REVUE DE MEDECINE INTERNE, 1991, 12 (06): : 458 - 464
  • [46] Intermittent cyclical etidronate therapy in the prevention and treatment of corticosteroid-induced osteoporosis.
    Adachi, J
    Roux, C
    Moniz, C
    Geusens, P
    Dequeker, J
    Webber, D
    Pack, S
    Ethgen, D
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 628 - 628
  • [47] Epidemiology of corticosteroid-induced osteoporosis
    Sanchez, Ariel
    ACTUALIZACIONES EN OSTEOLOGIA, 2021, 17 (01) : 7 - +
  • [48] Management of corticosteroid-induced osteoporosis
    Yeap, SS
    Hosking, DJ
    RHEUMATOLOGY, 2002, 41 (10) : 1088 - 1094
  • [49] Corticosteroid-induced osteoporosis - Reply
    Erb, N
    Duncan, R
    Raza, K
    Rowe, IF
    Kitas, GD
    Situnayake, RD
    RHEUMATOLOGY, 2003, 42 (09) : 1120 - 1120
  • [50] MANAGEMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS
    EASTELL, R
    JOURNAL OF INTERNAL MEDICINE, 1995, 237 (05) : 439 - 447